Stock Analysts’ Downgrades for September 3rd (AT, BMA, CVSA, FLNC, GGAL, MRNA, RARE, SON, TCOM, ZTO)

Stock Analysts’ downgrades for Thursday, September 3rd:

Ashtead Technology (LON:AT) was downgraded by analysts at Royal Bank Of Canada to a sector perform rating. The firm currently has GBX 400 price target on the stock, down from their previous price target of GBX 560.

Macro Bank (NYSE:BMA) was downgraded by analysts at Itau BBA Securities from an outperform rating to a market perform rating.

Adtalem Global Education (NYSE:CVSA) was downgraded by analysts at Truist Financial Corporation from a buy rating to a hold rating. They currently have $140.00 target price on the stock.

Fluence Energy (NASDAQ:FLNC) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. They currently have $10.00 target price on the stock.

Grupo Financiero Galicia (NASDAQ:GGAL) was downgraded by analysts at Itau BBA Securities from an outperform rating to a market perform rating.

Moderna (NASDAQ:MRNA) was downgraded by analysts at Rothschild & Co Redburn from a neutral rating to a sell rating. The firm currently has $81.00 price target on the stock, up from their previous price target of $40.00.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. They currently have $18.00 target price on the stock, down from their previous target price of $50.00.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $36.00 price target on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Evercore Inc from an outperform rating to an in-line rating. They currently have $16.00 price target on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.

Sonoco Products (NYSE:SON) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating. Bank of America Corporation currently has $60.00 target price on the stock, down from their previous target price of $69.00.

Trip.com Group (NASDAQ:TCOM) was downgraded by analysts at HSBC Holdings plc from a buy rating to a hold rating.

ZTO Express (Cayman) (NYSE:ZTO) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $22.00 price target on the stock.